Literature DB >> 24118683

A combination of interferon-gamma and interleukin-2 production by Coxiella burnetii-stimulated circulating cells discriminates between chronic Q fever and past Q fever.

T Schoffelen1, T Sprong, C P Bleeker-Rovers, M C A Wegdam-Blans, A Ammerdorffer, M J H Pronk, Y E P Soethoudt, M E E van Kasteren, T Herremans, H A Bijlmer, M G Netea, J W M van der Meer, L A B Joosten, M van Deuren.   

Abstract

Infection with Coxiella burnetii may lead to life-threatening chronic Q fever endocarditis or vascular infections, which are often difficult to diagnose. The present study aims to investigate whether measurement of in-vitro interferon-gamma (IFN-γ) production, a key cytokine in the immune response against C. burnetii, differentiates chronic from a past cleared infection, and whether measurement of other cytokines would improve the discriminative power. First, C. burnetii-specific IFN-γ production was measured in whole blood of 28 definite chronic Q fever patients and compared with 135 individuals with past Q fever (seropositive controls) and 908 seronegative controls. IFN-γ production was significantly higher in chronic Q fever patients than in controls, but with overlapping values between patients and seropositives. Secondly, the production of a series of other cytokines was measured in a subset of patients and controls, which showed that interleukin (IL)-2 production was significantly lower in patients than in seropositive controls. Subsequently, measuring IL-2 in all patients and all controls with substantial IFN-γ production showed that an IFN-γ/IL-2 ratio >11 had a sensitivity and specificity of 79% and 96%, respectively, to diagnose chronic Q fever. This indicates that a high IFN-γ/IL-2 ratio is highly suggestive for chronic Q fever. In an additional group of 25 individuals with persistent high anti-Coxiella phase I IgG titres without definite chronic infection, all but six showed an IFN-γ/IL-2 ratio <11. In conclusion, these findings hold promise for the often difficult diagnostic work-up of Q fever and the IFN-γ/IL-2 ratio may be used as an additional diagnostic marker.
© 2013 The Authors Clinical Microbiology and Infection © 2013 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Chronic Q fever; Coxiella burnetii; cytokines; diagnosis; interferon-gamma; interleukin-2

Mesh:

Substances:

Year:  2013        PMID: 24118683     DOI: 10.1111/1469-0691.12423

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  14 in total

Review 1.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Coxiella burnetii Epitope-Specific T-Cell Responses in Patients with Chronic Q Fever.

Authors:  Ann E Sluder; Anja Garritsen; Anja Scholzen; Guilhem Richard; Leonard Moise; Eva Hartman; Chantal P Bleeker-Rovers; Patrick M Reeves; Susan Raju Paul; William D Martin; Anne S De Groot; Mark C Poznansky
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.441

3.  Early cytokine and antibody responses against Coxiella burnetii in aerosol infection of BALB/c mice.

Authors:  Teske Schoffelen; Joshua S Self; Kelly A Fitzpatrick; Mihai G Netea; Marcel van Deuren; Leo A B Joosten; Gilbert J Kersh
Journal:  Diagn Microbiol Infect Dis       Date:  2014-12-30       Impact factor: 2.803

4.  Natural Exposure- and Vaccination-Induced Profiles of Ex Vivo Whole Blood Cytokine Responses to Coxiella burnetii.

Authors:  Susan Raju Paul; Anja Scholzen; Ghazel Mukhtar; Stephanie Wilkinson; Peter Hobson; Richard K Dzeng; Jennifer Evans; Jennifer Robson; Rowland Cobbold; Stephen Graves; Mark C Poznansky; Anja Garritsen; Ann E Sluder
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

5.  Viable Coxiella burnetii Induces Differential Cytokine Responses in Chronic Q Fever Patients Compared to Heat-Killed Coxiella burnetii.

Authors:  Anne F M Jansen; Annemieke Dinkla; Hendrik-Jan Roest; Chantal P Bleeker-Rovers; Teske Schoffelen; Leo A B Joosten; Peter C Wever; Marcel van Deuren; Ad P Koets
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

6.  Murine Alveolar Macrophages Are Highly Susceptible to Replication of Coxiella burnetii Phase II In Vitro.

Authors:  Talita D Fernandes; Larissa D Cunha; Juliana M Ribeiro; Liliana M Massis; Djalma S Lima-Junior; Hayley J Newton; Dario S Zamboni
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

7.  Specific in vitro interferon-gamma and IL-2 production as biomarkers during treatment of chronic Q fever.

Authors:  Teske Schoffelen; Marjolijn C Wegdam-Blans; Anne Ammerdorffer; Marjolijn J H Pronk; Yvonne E P Soethoudt; Mihai G Netea; Jos W M van der Meer; Chantal P Bleeker-Rovers; Marcel van Deuren
Journal:  Front Microbiol       Date:  2015-02-12       Impact factor: 5.640

8.  The effect of C. burnetii infection on the cytokine response of PBMCs from pregnant goats.

Authors:  Anne Ammerdorffer; Hendrik-I J Roest; Annemieke Dinkla; Jacob Post; Teske Schoffelen; Marcel van Deuren; Tom Sprong; Johanna M Rebel
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

9.  Coxiella burnetii Employs the Dot/Icm Type IV Secretion System to Modulate Host NF-κB/RelA Activation.

Authors:  Saugata Mahapatra; Brandi Gallaher; Sydni Caet Smith; Joseph G Graham; Daniel E Voth; Edward I Shaw
Journal:  Front Cell Infect Microbiol       Date:  2016-12-19       Impact factor: 5.293

10.  Diagnosis of Coxiella burnetii infection: comparison of a whole blood interferon-gamma production assay and a Coxiella ELISPOT.

Authors:  Teske Schoffelen; Gijs J M Limonard; Chantal P Bleeker-Rovers; John J M Bouwman; Jos W M van der Meer; Marrigje Nabuurs-Franssen; Tom Sprong; Marcel van Deuren
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.